Shah Preetam

CIK 00017874033 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001787403

Recent Transactions

23 trades

Award
Elicio Therapeutics, Inc.$ELTX
Stock Option (Right to Buy)
2025-04-15+191,624→ 191,624 total
Award
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2024-09-30+130,087→ 130,087 total
Award
Cidara Therapeutics, Inc.$CDTX
Common Stock
2024-03-15+108,750→ 335,960 total
Award
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2024-03-15+217,500→ 217,500 total
Sale
Cidara Therapeutics, Inc.$CDTX
Common Stock
2024-03-11$0.67/sh−18,931→ 227,210 total
Award
Cidara Therapeutics, Inc.$CDTX
Common Stock
2023-03-27+90,000→ 238,141 total
Award
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2023-03-27+180,000→ 180,000 total
Sale
Cidara Therapeutics, Inc.$CDTX
Common Stock
2023-03-13$1.53/sh−6,648→ 148,141 total
Sale
Cidara Therapeutics, Inc.$CDTX
Common Stock
2022-09-19$0.77/sh−15,642→ 150,789 total
Exercise/Conversion
Cidara Therapeutics, Inc.$CDTX
Common Stock
2022-09-15+50,000→ 166,431 total
Exercise/Conversion
Cidara Therapeutics, Inc.$CDTX
Restricted Stock Unit
2022-09-15−50,000→ 0 total
Tax Payment
Cidara Therapeutics, Inc.$CDTX
Common Stock
2022-03-31$0.83/sh−24,820→ 112,431 total
Award
Cidara Therapeutics, Inc.$CDTX
Common Stock
2022-03-31+51,250→ 71,250 total
Award
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2022-03-31+102,500→ 102,500 total
Award
Cidara Therapeutics, Inc.$CDTX
Common Stock
2022-03-31+66,001→ 137,251 total
Purchase
Cidara Therapeutics, Inc.$CDTX
Common Stock
2021-11-12$1.54/sh+20,000→ 20,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Restricted Stock Unit
2021-09-01+50,000→ 50,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2021-09-01+311,850→ 311,850 total
Tax Payment
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2020-12-30$4.64/sh−25,000→ 11,600 total
Purchase
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2019-12-24$3.96/sh+11,600→ 36,600 total
Award
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2019-09-06+25,000→ 25,000 total
Award
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Stock Option (right to buy)
2019-09-06+100,000→ 100,000 total
Award
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Stock Option (right to buy)
2019-09-06+100,000→ 100,000 total

Companies

Recent Filings

Address

C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501

BOSTON, MA, 02210

View on SEC.gov